Trichlormas and Tarceva drug interactions - a phase IV clinical study of FDA data
Summary:
We study 31,036 people who take Trichlormas (trichlormethiazide) and Tarceva (erlotinib hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Trichlormas and Tarceva. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Trichlormas?
Trichlormas has active ingredients of trichlormethiazide.
What is Tarceva?
Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.
No report is found.
Do you take Trichlormas and Tarceva?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Trichlormas
- Tarceva (31,036 reports)
How the study uses the data?
The study uses data from the FDA. It is based on trichlormethiazide and erlotinib hydrochloride (the active ingredients of Trichlormas and Tarceva, respectively), and Trichlormas and Tarceva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Allegra-D 12 Hour and Stress And Anxiety for Women aged 50-59 - a second ago
- Allegra-D 12 Hour and Anxiolytic Therapy for Women aged 50-59 - a second ago
- Allegra-D 12 Hour and Anxiety And Stress for Women aged 50-59 - 2 seconds ago
- Allegra-D 12 Hour and Tension for Women aged 50-59 - 2 seconds ago
- Allegra-D 12 Hour and Stress for Women aged 50-59 - 2 seconds ago
- Allegra-D 12 Hour and Jitters for Women aged 50-59 - 2 seconds ago
- Allegra-D 12 Hour and Feeling Uptight for Women aged 50-59 - 3 seconds ago
- Allegra-D 12 Hour and Apprehension for Women aged 50-59 - 3 seconds ago
- Allegra-D 12 Hour and Anxiety for Women aged 50-59 - 3 seconds ago
- Allegra-D 12 Hour and Anxiety, Apprehension, Feeling Uptight, Jitters, Stress, Stress And Anxiety, Tension for Women aged 50-59 - 4 seconds ago